SCHEMBL11091048

SCHEMBL11091048

O=c1ccocc1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18983058 0.83 ALOX5 (0.31)
SCHEMBL9946484 0.79
SCHEMBL9700115 0.78 CYP3A4 (0.36)
SCHEMBL3657249 0.77 AKR1B1 (0.41)
SCHEMBL4651248 0.74
SCHEMBL4582881 0.70 MAOB (0.47)
SCHEMBL588597 0.69
SCHEMBL6665441 0.67 MMP2 (0.50)
SCHEMBL6021918 0.67
Hydrochloric Acid SCHEMBL22711054 0.67 MMP2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293459-A1 OLEYLCYSTEINEAMIDE OR DERIVATIVES THEREOF AND THEIR USE IN THERAPY HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED (IL) 2023-09-21 US disclosed
CN-116437907-A Oleyl cystein amides or derivatives thereof and their use in therapy 耶路撒冷希伯来大学伊森姆研究发展有限公司 2023-07-14 CN disclosed
EP-4192441-A1 OLEYLCYSTEINEAMIDE OR DERIVATIVES THEREOF AND THEIR USE IN THERAPY Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2023-06-14 EP disclosed
WO-2022029785-A1 OLEYLCYSTEINEAMIDE OR DERIVATIVES THEREOF AND THEIR USE IN THERAPY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2022-02-10 WO disclosed
US-4471129-A ANTIHISTAMINES LILLY INDUSTRIES LIMITED (GB) 1984-09-11 US disclosed